Austedo vs ingrezza cost?

Both Austedo (deutetrabenazine) and Ingrezza (valbenazine) are brand-name VMAT2 inhibitors used for tardive dyskinesia. There is no generic version, so the list price is high for both. The exact out-of-pocket you pay depends on your dose, insurance plan, and location.

What to know about cost
- Typical monthly cost: In the United States, both drugs are generally in the range of several thousand dollars per month at list price, often described as “tens of thousands” per month depending on dose. Your actual out-of-pocket is usually much lower with insurance, but it can still be hundreds to thousands of dollars if you have high copays or deductible.
- Dose matters a lot: Higher daily doses mean higher monthly costs. Ingrezza is generally taken in 40 mg/day or 80 mg/day (split dosing), while Austedo is started lower (e.g., 12 mg/day) and may be increased up to around 48 mg/day. The higher your prescribed dose, the higher the price.
- Insurance impact: Many commercial plans place these drugs on a specialty tier with copays or coinsurance. Medicare Part D and other programs may reduce out-of-pocket substantially, especially with prior authorization in place.
- No generics: Both drugs are brand-only in the US, so you won’t see generic price reductions.
- Savings programs: Both manufacturers offer patient savings/assistance programs to help reduce out-of-pocket costs for eligible patients. This can bring your cost down significantly if you qualify.

How to check your exact cost
- Ask the pharmacist for the cash price and your insurance price for your exact dose.
- Check your insurer’s formulary to see placement (tier) and any required prior authorization.
- Compare with a discount price on a site like GoodRx (note: GoodRx price may differ from what your insurer actually pays).
- Look into patient assistance programs:
- Ingrezza: manufacturer-based patient assistance and savings programs (may help uninsured/underinsured).
- Austedo: similar savings program or co-pay assistance depending on program terms.
- If you’re eligible for Medicare Part D or Medicaid, check the specific plan’s coverage and credits, which can drastically reduce out-of-pocket.

If you’d like, tell me:
- Which country you’re in
- Your insurance type (commercial, Medicare, Medicaid, uninsured)
- Your planned or current dose (approx. mg per day)
- Any known deductible or copay amounts

With that, I can give a more tailored estimate of your monthly out-of-pocket and point you to the most relevant savings options.